account_balance
Investment manager · 13F filer · SEC CIK 1802630
Soleus Capital Management, L.P.
Reported value$2.9Bas of Jun 30, 2026
Positions97 22 new, 18 sold out
Top 10 weight48.9%KRYS alone is 12%
FiledAug 1142 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
KRYSKrystal Biotech Inc
12.0%Trimmed −19%
CELCCelcuity Inc
6.1%Added +33%
TGTXTg Therapeutics Inc
5.5%Trimmed −27%
PODDInsulet Corp
5.5%Added +86%
NVCRNovocure Ltd
5.2%Trimmed −6%
UTHRUnited Therapeutics Corp
4.2%Added +21%
INSPInspire Med Sys Inc
3.0%Added +235%
RIGLRigel Pharmaceuticals Inc
2.5%Added +18335%
ANIPAni Pharmaceuticals Inc
2.5%Added +6%
BBNXBeta Bionics Inc
2.4%
VCELVericel Corp
2.2%Trimmed −43%
PRAXPraxis Precision Medicines I
2.0%Trimmed −46%
KRYSKrystal Biotech Inc
12.0%Trimmed −19%
CELC6.1%TGTX5.5%PODD5.5%NVCRNovocure Ltd
5.2%Trimmed −6%
UTHR4.2%INSP3.0%RIGL2.5%ANIP2.5%BBNX2.4%VCEL2.2%PRAX2.0%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
KRYS Krystal Biotech Inc 12.0% Trimmed −19%CELC Celcuity Inc 6.1% Added +33%TGTX Tg Therapeutics Inc 5.5% Trimmed −27%PODD Insulet Corp 5.5% Added +86%NVCR Novocure Ltd 5.2% Trimmed −6%UTHR United Therapeutics Corp 4.2% Added +21%INSP Inspire Med Sys Inc 3.0% Added +235%RIGL Rigel Pharmaceuticals Inc 2.5% Added +18335%ANIP Ani Pharmaceuticals Inc 2.5% Added +6%BBNX Beta Bionics Inc 2.4% HeldVCEL Vericel Corp 2.2% Trimmed −43%PRAX Praxis Precision Medicines I 2.0% Trimmed −46%
What changed